Circulating Tumor Cells in Melanoma Patients
Open Access
- 19 July 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7) , e41052
Abstract
Circulating tumor cells (CTCs) are of recognized importance for diagnosis and prognosis of cancer patients. With melanoma, most studies do not show any clear relationship between CTC levels and stage of disease. Here, CTCs were enriched (∼400X) from blood of melanoma patients using a simple centrifugation device (OncoQuick), and 4 melanocyte target RNAs (TYR, MLANA, MITF, and MIF) were quantified using QPCR. Approximately one-third of melanoma patients had elevated MIF and MLANA transcripts (p<0.0001 and p<0.001, respectively) compared with healthy controls. In contrast, healthy controls had uniformly higher levels of TYR and MITF than melanoma patients (p<0.0001). There was a marked shift of leukocytes into the CTC-enriched fractions (a 430% increase in RNA recovery, p<0.001), and no relationship between CTC levels and stage of disease was found. CTCs were captured on microfabricated filters and cultured. Captured melanoma CTCs were large cells, and consisted of 2 subpopulations, based on immunoreactivity. One subpopulation (∼50%) stained for both pan-cytokeratin (KRT) markers and the common leukocyte marker CD-45, whereas the second subpopulation stained for only KRT. Since similar cells are described in many cancers, we also examined blood from colorectal and pancreatic cancer patients. We observed analogous results, with most captured CTCs staining for both CD-45/KRT markers (and for the monocyte differentiation marker CD-14). Our results suggest that immature melanocyte-related cells (expressing TYR and MITF RNA) may circulate in healthy controls, although they are not readily detectable without considerable enrichment. Further, as early-stage melanomas develop, immature melanocyte migration into the blood is somehow curtailed, whereas a significant proportion of patients develop elevated CTC levels (based on MIF and MLANA RNAs). The nature of the captured CTCs is consistent with literature describing leukocyte/macrophage-tumor cell fusion hybrids, and their role in metastatic progression.Keywords
This publication has 51 references indexed in Scilit:
- “Stealth” Melanoma Cells in Histology-negative Sentinel Lymph NodesAmerican Journal of Surgical Pathology, 2011
- Clinical Utility of Serum Autoantibodies Detected by Protein Microarray in MelanomaInternational Journal of Proteomics, 2011
- Green Tea Catechins Reduce Invasive Potential of Human Melanoma Cells by Targeting COX-2, PGE2 Receptors and Epithelial-to-Mesenchymal TransitionPLOS ONE, 2011
- Generation of Human Melanocytes from Induced Pluripotent Stem CellsPLOS ONE, 2011
- Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patientsBMC Cancer, 2010
- Expression of the stem cell marker nestin in peripheral blood of patients with melanomaBritish Journal of Dermatology, 2010
- mRNA Expression and BRAF Mutation in Circulating Melanoma Cells Isolated from Peripheral Blood with High Molecular Weight Melanoma-Associated Antigen-Specific Monoclonal Antibody BeadsClinical Chemistry, 2009
- Altered gene expression in breast cancer liver metastasesInternational Journal of Cancer, 2009
- Chapter 10 The Cancer Cell–Leukocyte Fusion Theory of Metastasis2008
- Molecular diagnostics in melanomaJournal of the American Academy of Dermatology, 2005